Last reviewed · How we verify

NCT05433038

Effects of Skeletally Anchored Maxillary Expander Via Two Approaches of Microosteoperforations

Status unknown NA Last updated 27 June 2022
What this trial tests

NA trial testing skeletally anchored maxillary expander in Posterior Crossbite in 20 participants. Status unknown.

Timeline
20 May 2022
Primary endpoint
20 April 2024
1 November 2024

Quick facts

Lead sponsorAl-Azhar University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment20
Start date20 May 2022
Primary completion20 April 2024
Estimated completion1 November 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Al-Azhar University

Who can join

Adults 18 to 22, any sex, with Posterior Crossbite. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

study will be directed to evaluate two approaches of microosteoperforations during skeletally anchored maxillary expansion

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Al-Azhar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05433038.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing